Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria. | J Med Chem | 2022 | 35229610 | PubTator, text mining | PubMed |
| CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer. | Front Immunol | 2022 | 35222392 | PubTator, text mining | PubMed |
| Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease. | J Nephrol | 2022 | 35218550 | PubTator, text mining | PubMed |
| Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment. | Pharmaceutics | 2022 | 35214133 | PubTator, text mining | PubMed |
| Oligonucleotide Therapeutics: From Discovery and Development to Patentability. | Pharmaceutics | 2022 | 35213992 | PubTator, text mining | PubMed |
| Interdisciplinary Approach to Biological and Health Implications in Selected Professional Competences. | Brain Sci | 2022 | 35203999 | PubTator, text mining | PubMed |
| [Interfering RNA and antisense oligonucleotide treatments currently available in France: An update]. | Bull Acad Natl Med | 2022 | 35194225 | PubTator, text mining | PubMed |
| Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids. | Cytotherapy | 2022 | 35190267 | PubTator, text mining | PubMed |
| Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya. | Adv Virol | 2022 | 35186083 | PubTator, text mining | PubMed |
| Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population. | Lipids Health Dis | 2022 | 35184720 | PubTator, text mining | PubMed |
| Fatty acid transport protein 2 interacts with ceramide synthase 2 to promote ceramide synthesis. | J Biol Chem | 2022 | 35181339 | PubTator, text mining | PubMed |
| Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. | JAMA Netw Open | 2022 | 35171259 | PubTator, text mining | PubMed |
| The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia. | Int J Mol Sci | 2022 | 35163176 | PubTator, text mining | PubMed |
| The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges. | Int J Mol Sci | 2022 | 35163063 | PubTator, text mining | PubMed |
| Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis. | Kidney Int Rep | 2022 | 35155875 | PubTator, text mining | PubMed |
| Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry. | Kidney Int Rep | 2022 | 35155860 | PubTator, text mining | PubMed |
| The role of the microRNA regulatory network in Alzheimer's disease: a bioinformatics analysis. | Arch Med Sci | 2022 | 35154541 | PubTator, text mining | PubMed |
| Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy. | Cancer Cell | 2022 | 35148814 | PubTator, text mining | PubMed |
| Oxalate nephropathy: a review. | Clin Kidney J | 2022 | 35145635 | PubTator, text mining | PubMed |
| Liver transplant allocation policies and outcomes in United States: A comprehensive review. | World J Methodol | 2022 | 35117980 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=41